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Does dispensing naloxone kits to high-risk patients at
the time of emergency department (ED) discharge
reduce the burden of subsequent overdose-related care?
Steve Perry, Pharm D; Charleen Melton, Pharm D, BCCCP; Rachel Beham, Pharm D | HCA
Introduction

Objectives and Outcomes

•

Excessive opioid prescribing in the late 1990s and 2000s led to
diversion and misuse of these useful but potentially dangerous drugs

•

The CDC issued revised opioid prescribing guidelines in 2016 which
favor non-opioid strategies for pain control and recommend avoiding or
limiting the use of opioids when possible

•

Opioid-related overdose and death have remained at or near
historically high levels despite reform in opioid prescribing trends.

•

Per National Institute on Druga Abuse 2017 data1:

•

•

Primary objective: determine if providing take-home naloxone emergency
kits to high-risk patients reduces the subsequent institutional and regional
burden of acute overdose-related medical care to a greater degree than
providing written outpatient naloxone prescriptions
Primary outcomes
– Rate of hospital and ED readmission for care related to opioid intoxication

Naloxone kits: patients will be identified through internal audit of
dispense reports for naloxone kits removed from Pyxis in the ED

•

Written naloxone prescriptions

• Need for supplemental oxygenation
•

Secondary outcomes
– Average cumulative dose of naloxone required by readmitted patients

– 47,000 annual opioid overdose-related deaths

– Discharge disposition of readmitted patients

– Estimated annual economic burden of $78.5 billion

Background

•

–

ICD-10 codes will be used to identify patients with admissions
potentially related to opioid overdose

–

Electronic health record (EHR) discharge notes will be reviewed to
identify patients who received written outpatient prescriptions

Exclusion criteria: patients will be excluded from analysis if they are
less than 18 years old, are pregnant or incarcerated at time of
intervention, or do not require naloxone because they already have a
dose at home

Hypothesis

In December 2018, Swedish Medical Center implemented the
Outpatient Intranasal Naloxone protocol in the ED

•

Patients visiting the ED who are determined to be at risk for opioid
overdose may be eligible at discharge to receive a free naloxone
emergency kit or written prescription for naloxone based on a providerimplemented decision making tree as outlined below

•

Baseline characteristics

Outcomes

• Age

Previous research indicates that only 29% of naloxone prescriptions
written in EDs are ever actually filled at an outpatient pharmacy2

• Type of opioid intake

• For HealthONE division hospitals,
outcomes will be determined through
internal EHR review for patients who
received either intervention at
Swedish Medical Center

Does the patient meet all of the following criteria
• Is being discharged from ED during daytime hours (7am – 7pm)
• Has insurance (including Medicaid)
• Is reliable and is able to get to a pharmacy
• Verbally commits to fill prescription
NO
Provider should
consider dispensing
naloxone at ED
discharge

YES

• Sex
• Criteria patient met to receive
either naloxone intervention
• Comorbidities that may be
exacerbated by or treated in
conjunction with overdose

Does the patient meet any of the following criteria
• Received emergency care for opioid intoxication or overdose
• Have suspected substance abuse or non-medical opioid use
• Are taking >100mg morphine equivalents per day
• Are IV heroin or opioid users
• Have concurrent use of benzodiazepines or other sedatives
YES

Data collection

By getting free naloxone kits into the hands of at-risk patients at ED
discharge, the burden of opioid overdose-related care will be reduced
at the source institution and on a regional level to a greater degree than
in patients who receive outpatient naloxone prescriptions

Provider-Based Decision Tree

YES
Provider should
consider writing an
outpatient prescription
for naloxone

•

• Need for intubation and mechanical ventilation

– 650,000 Americans with a heroin use disorder

•

Patient identification

– Rate of hypoxic complications or death

– 1.7 million Americans with prescription opioid abuse disorder

•

Methods

– Diabetes
– COPD
– Cardiac disorders
– Infectious diseases

NO
Does the patient meet any of the additional criteria
• Are receiving an opioid for pain plus
• Are prescribed methadone or buprenorphine
• Have poorly controlled respiratory disease or infection
• Have renal dysfunction, hepatic disease, or cardiac comorbidities
• Have known or suspected alcohol use or dependency
• Recent incarceration/release from prison with history of opioid use
• Resumption of opioid use for pain and with a history of opioid use
disorder that is in remission
NO
Dispensing naloxone or writing outpatient
prescription is not indicated

• Outcomes will be determined for
patients that receive either
intervention at Swedish Medical
Center but receive overdose-related
care at hospitals outside of the
HealthONE through chart review in
CORHIO, a regional EHR database
that the majority of Denver Metro
hospitals report to
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